GSK-3 inhibitor inhibits cell proliferation and induces apoptosis in human osteosarcoma cells.

Authors: HIDEKI NISHIMURA, OSAMU NAKAMURA, YOSHIKI YAMAGAMI, MASAKI MORI, RYOSUKE HORIE, NATSUKO FUKUOKA, TETSUJI YAMAMOTO

Source: Oncology Reports; 2016, Vol. 35 Issue 4, p2348-2354, 7p

Apoptosis and antitumor effects induced by the combination of an mTOR inhibitor and an autophagy inhibitor in human osteosarcoma MG63 cells.

Authors: RYOSUKE HORIE, OSAMU NAKAMURA, YOSHIKI YAMAGAMI, MASAKI MORI, HIDEKI NISHIMURA, NATSUKO FUKUOKA, TETSUJI YAMAMOTO

Source: International Journal of Oncology; Jan2016, Vol. 48 Issue 1, p37-44, 8p

Hsp90 inhibitor induces autophagy and apoptosis in osteosarcoma cells.

Authors: MASAKI MORI, TOSHIAKI HOTORA, OSAMU NAKAMURA, YOSHIKI YAMAGAMI, RYOSUKE HORIE, HIDEKI NISHIMURA, TETSUJI YAMAMOTO

Source: International Journal of Oncology; 2015, Vol. 46 Issue 1, p47-54, 8p

The combination of rapamycin and MAPK inhibitors enhances the growth inhibitory effect on Nara-H cells.

Authors: OSAMU NAKAMURA, TOSHIAKI HITORA, YOSHIKI YAMAGAMI, MASAKI MORI, HIDEKI NISHIMURA, RYOSUKE HORIE, KONOSUKE YAMAGUCHI, TETSUJI YAMAMOTO

Source: International Journal of Molecular Medicine; 2014, Vol. 33 Issue 6, p1491-1497, 7p